Mao Inhibitors + Palovarotene Interaction
Majorinteraction on record
Description
Co-administration increases palovarotene exposure, which may increase risk of adverse reactions. Avoid concomitant use.
Mechanism
CYP3A4 inhibition
Source: NLP:palovarotene